0.33
0.33 (0%)
As of Feb 14, 2025
Virpax Pharmaceuticals, Inc. [VRPX]
Source:
Company Overview
Virpax Pharmaceuticals, Inc is a preclinical-stage pharmaceutical company focused on developing novel and proprietary drug delivery systems across various pain indications in order to enhance compliance and optimize each product candidate in our pipeline.
| Country | United States |
| Headquarters | berwyn, pennsylvania |
| Phone Number | (610) 727-4597 |
| Industry | manufacturing |
| CEO | Gerald Bruce |
| Website | www.clinicaltrials.gov |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-12.1 |
| Net Income | $-12.1 |
| Net Cash | $-7.6 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -215.8% |
| Profit as % of Stockholder Equity | 1,320.6% |
Management Effectiveness
| Return on Equity | 1,320.6% |
| Return on Assets | -775.7% |
| Turnover Ratio | |
| EBITA | $-12.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1.6 |
| Total Liabilities | $2.5 |
| Operating Cash Flow | $-16.7 |
| Investing Cash Flow | |
| Financing Cash Flow | $9.1 |
